Methods for the detection and treatment of aberrant prion disease

Details for Australian Patent Application No. 2010227529 (hide)

Owner Protea Biopharma N.V.

Inventors Roelant, Christiaan; De Meirleir, Kenny

Agent Griffith Hack

Pub. Number AU-A-2010227529

PCT Pub. Number WO2010/109009

Priority 09156467.4 27.03.09 EP

Filing date 26 March 2010

Wipo publication date 30 September 2010

International Classifications

C12N 9/02 (2006.01) Enzymes, e.g. ligases (6.) - Oxidoreductases (1.), e.g. luciferase

C12Q 1/26 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving oxidoreductase

Event Publications

13 October 2011 PCT application entered the National Phase

  PCT publication WO2010/109009 Priority application(s): WO2010/109009

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010227531-Film for production of composite material artefacts, production method of said film and production method of composite material artefacts using said film

2010227527-Tricyclic indole derivates as PBR ligands